The fundamental purpose of the IRB is for the protection of human subjects in research. The IRB committee reviews and monitors research projects according to federal regulations. The IRB also assists in the education of those involved in research. A Clinical Research Newsletter (CRN) was developed as an educational outreach source for professional staff and employees. The CRN is generated monthly with featured articles of continued education and newly approved research projects.


Cleveland Clinic's Institutional Review Board consists of members including both staff-level and resident physicians, administrative personnel, nursing personnel, and non-affiliated lay people to represent the community. Continual development of IRB studies ensures the highest possible standard of health care for patients in South Florida.

Institutional Review Board
Cleveland Clinic Foundation
9500 Euclid Avenue
Cleveland, OH 44195 
Telephone: 800.223.2273
Fax: 216.445.4094 

IRB Chairman: Alan Lichtin, MD
Executive Director: Bridget Howard, JD
Frequency of  IRB meetings: Weekly
Day of IRB convened meeting: Fridays
Deadline of research submissions:  By 5 pm Wednesday for review the following week on Friday  
Timeframe for IRB approval letter: 2-3 business days after the convened IRB meeting.

Scope of Review

IRB review is required for any research involving human subjects.